Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Media Resources
2023
Statement to the Fifth Meeting of the Intergovernmental Negotiating Body
Statement to WHA76 – UHC
Statement to WHA76 – Health Emergencies
Joint Statement on the Impact of Artificial Intelligence on Health Outcomes for Key Populations: Navigating Health Inequalities in the EU
Statement to US International Trade Commission Public Hearing on COVID-19
WHO EURO Access to Novel Medicines Platform
Statement following latest session of the European Parliament’s COVI Committee
Statement to the Fourth Meeting of the Intergovernmental Negotiating Body – Consideration and Negotiation of the Zero Draft of the WHO Convention
Statement to the 152nd WHO Executive Board – Falsified and Substandard Medicines
Lack of diagnostic use hampering fight against antimicrobial resistance
2022
Statement to WHO Euro RC72
HAI and Partners Launch SHARP Project
HAI Statement on Tentative Agreement on TRIPS and COVID-19
Statement to EB150: Global Strategy & Plan of Action
Statement to EB150: Pandemic Preparedness and Response
2021
Statement on Pandemic Prevention, Preparedness and Response
Spanish Research Institute Licence with C-TAP
Oproep aan Nederlandse regering: toon politieke daadkracht tijdens topconferenties en promoot eerlijke toegang tot Covid-19 vaccins
Letter to the President of the European Council: European Council Meeting 20-21 October and TRIPS Waiver
New study estimates over nine million people living with type 1 diabetes
Analogue Insulin on WHO Model List of Essential Medicines
MEPs can deliver strong message to Commission on TRIPS waiver
WHO Members States must not miss opportunity to improve lives of over 460 million people with diabetes
Nearly 400 MEPs and MPs Join Chorus of Voices Calling for a TRIPS Waiver on COVID-19 Vaccines
HAI Statement on the Oslo Medicines Initiative
2020